A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
Clinical trial NCT04590235 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04590235
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2022-08-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.